COMP breaks through $70
The market shows that COMP has broken through $70, currently quoted at $71.16, with an intraday increase of 20.7%. The market fluctuation is quite large, please manage your risk well.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Signs of Strength in U.S. Economy Power Stocks -- WSJ
Silver Price Forecast: XAG/USD remains vulnerable near $60

BMO analyst: The cooling of inflation exceeded expectations
Roche (RHHBY.US) BTK inhibitor submitted for listing
On September 30, Roche (RHHBY.US) announced that the U.S. FDA has accepted the New Drug Application (NDA) for its non-covalent BTK inhibitor, fenebrutinib.